Autopsy report · NCT03430687

Talimogene Laherparepvec in Treating Patients With Non-Muscle Invasive Bladder Transitional Cell Carcinoma

“Investigators prefer to pursue other studies”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

University of California, San Francisco

Sponsor type

University, hospital or other

Conditions

Stage 0 Bladder Urothelial Carcinoma AJCC v6 and v7; Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7; Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7; Stage I Bladder Urothelial Carcinoma AJCC v6 and v7

Interventions

Laboratory Biomarker Analysis; Talimogene Laherparepvec

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Apremilast in the Treatment of Uveitis
  “Investigator discretion due to lack of efficacy in three subjects enrolled” (65% match in meaning)
• Use of Magnetic Imaging to Asses the Efficacy of Cap Assisted Colonoscopy in Reducing Looping and Improving Patient Acceptance for the Colonoscopy Procedure
  “The study was incorporated in another study.” (63% match in meaning)
• Muscle Function and Muscle Ultrasound in ICU
  “inclusion difficulties and reorganization of the principal investigator's activity” (62% match in meaning)
• A Study of Intra-Ophthalmic Artery Topotecan Infusion for the Treatment of Retinoblastoma
  “Competing studies” (62% match in meaning)
• Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin
  “Investigator's decision” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.